BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8144186)

  • 1. The effect of bryostatin on protein kinase C-regulated functions in human T lymphocytes and epidermal keratinocytes.
    Galron D; Tamir A; Gelkop S; Grossman N; Isakov N
    Immunol Lett; 1993 Dec; 39(1):17-22. PubMed ID: 8144186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C.
    Isakov N; Galron D; Mustelin T; Pettit GR; Altman A
    J Immunol; 1993 Feb; 150(4):1195-204. PubMed ID: 8432975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of T-cells by bryostatins: induction of the IL-2 receptor gene transcription and down-modulation of surface receptors.
    Esa AH; Boto WO; Adler WH; May WS; Hess AD
    Int J Immunopharmacol; 1990; 12(5):481-90. PubMed ID: 2210911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
    Levine BL; May WS; Tyler PG; Hess AD
    J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human T lymphocytes by bryostatin.
    Hess AD; Silanskis MK; Esa AH; Pettit GR; May WS
    J Immunol; 1988 Nov; 141(10):3263-9. PubMed ID: 3263418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
    Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
    Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dephosphorylation of activated protein kinase C contributes to downregulation by bryostatin.
    Lee HW; Smith L; Pettit GR; Bingham Smith J
    Am J Physiol; 1996 Jul; 271(1 Pt 1):C304-11. PubMed ID: 8760059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PMA-induced human T cell proliferation by bryostatin is associated with enhanced degradation of conventional protein kinase C (cPKC): Ca2+ signals restore mitogenic activity without abrogating enhanced cPKC degradation.
    Galron D; Tamir A; Altman A; Isakov N
    Cell Immunol; 1994 Oct; 158(1):195-207. PubMed ID: 8087865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bryostatin-1 enhances the maturation and antigen-presenting ability of murine and human dendritic cells.
    Do Y; Hegde VL; Nagarkatti PS; Nagarkatti M
    Cancer Res; 2004 Sep; 64(18):6756-65. PubMed ID: 15374994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation.
    Hocevar BA; Morrow DM; Tykocinski ML; Fields AP
    J Cell Sci; 1992 Mar; 101 ( Pt 3)():671-9. PubMed ID: 1522149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation.
    Drexler HG; Gignac SM; Pettit GR; Hoffbrand AV
    Eur J Immunol; 1990 Jan; 20(1):119-27. PubMed ID: 1689659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of bryostatin 1 on human lymphocyte-mediated cytotoxicity.
    Tilden AB; Kraft AS
    J Immunother (1991); 1991 Apr; 10(2):96-104. PubMed ID: 1828367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines.
    Steube KG; Grunicke D; Drexler HG
    Invest New Drugs; 1994; 12(1):15-23. PubMed ID: 7960600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The catalytic domain of protein kinase Cdelta confers protection from down-regulation induced by bryostatin 1.
    Lorenzo PS; Bögi K; Acs P; Pettit GR; Blumberg PM
    J Biol Chem; 1997 Dec; 272(52):33338-43. PubMed ID: 9407126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the protein kinase C stimulant bryostatin 1 on the proliferation and colony formation of irradiated human T-lymphocytes.
    Sung SJ; Lin PS; Schmidt-Ullrich R; Hall CE; Walters JA; McCrady C; Grant S
    Int J Radiat Biol; 1994 Dec; 66(6):775-83. PubMed ID: 7814976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bryostatin 1 and phorbol ester down-modulate protein kinase C-alpha and -epsilon via the ubiquitin/proteasome pathway in human fibroblasts.
    Lee HW; Smith L; Pettit GR; Smith JB
    Mol Pharmacol; 1997 Mar; 51(3):439-47. PubMed ID: 9058599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation and growth modulation of myeloid leukemia cells by the protein kinase C activating agent bryostatin-1.
    Steube KG; Drexler HG
    Leuk Lymphoma; 1993 Jan; 9(1-2):141-8. PubMed ID: 8477194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differing modulation of protein kinase C by bryostatin 1 and phorbol esters in JB6 mouse epidermal cells.
    Kraft AS; Reeves JA; Ashendel CL
    J Biol Chem; 1988 Jun; 263(17):8437-42. PubMed ID: 3286649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of the two protein kinase C activators bryostatin-1 and TPA on growth and differentiation of human monocytic leukemia cell lines.
    Steube KG; Grunicke D; Quentmeier H; Drexler HG
    Leuk Res; 1993 Oct; 17(10):897-901. PubMed ID: 8412301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttranslational regulation of Lck and a p36-38 protein by activators of protein kinase C: differential effects of the tumor promoter, PMA, and the non-tumor-promoter, bryostatin.
    Galron D; Ansotegui IJ; Isakov N
    Cell Immunol; 1997 Jun; 178(2):141-51. PubMed ID: 9225005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.